FDA 510(k) Clearances - May 2021

194 medical devices cleared by the FDA. Data sourced from the FDA 510(k) public files.

194
Cleared
16
Specialties
155d
Avg review

May 2021 overview

The FDA cleared 194 medical devices in May 2021 through the 510(k) premarket notification pathway. This compares to 255 clearances in April 2021 - a decrease of 61 (-23.9%).

General Hospital led all specialties with 34 cleared devices. The fastest average review was Immunology at 29 days. The slowest was Chemistry at 389 days.

Overall average review time: 155 days, ranging from 14 to 796 days. The FDA's standard 510(k) review target is 90 days.

Clearances by specialty - May 2021

Detailed data

Review time in calendar days from FDA receipt to decision. Source: FDA 510(k) downloadable files.

Specialty Cleared Avg days Min Max vs April
General Hospital 34 152 28 396 -1
Orthopedic 33 137 21 445 -18
General & Plastic Surgery 25 148 24 345 -3
Cardiovascular 24 121 28 287 -2
Radiology 20 111 14 435 -18
Gastroenterology & Urology 13 117 29 223 -5
Physical Medicine 11 198 14 780 +6
Dental 11 219 54 436 -6
Obstetrics & Gynecology 5 234 144 370 -2
Neurology 5 319 25 796 -6
Ophthalmic 4 164 53 241 -5
Anesthesiology 3 211 131 293 -4
Ear, Nose, Throat 2 152 30 273 +2
Chemistry 2 389 280 497 +1
Microbiology 1 266 266 266 +1
Immunology 1 29 29 29 +1
Total 194 155 14 796 -61

Key observations

Fastest reviews

The fastest individual clearance took 14 days. Reviews under 5 days typically reflect Special 510(k) submissions for minor modifications to already-cleared devices.

Longest review

The longest individual review reached 796 days. Extended reviews typically indicate additional information requests or complex predicate device questions. The FDA's standard target is 90 days from receipt.

Leading specialty: General Hospital

General Hospital led May 2021 with 34 clearances - 18% of all monthly clearances.

Review time spread

Chemistry posted the highest average at 389 days. Immunology was fastest at 29 days. The gap of 360 days between fastest and slowest specialties reflects differences in device complexity and regulatory pathway.

Most active manufacturers

The most active manufacturers in May 2021 were Boston Scientific Corporation (3) , Medtronic, Inc. (2) , Medtronic Sofamor Danek USA, Inc. (2) , Nu Vasive, Incorporated (2) and Bausch & Lomb, Incorporated (2) . Together, these five manufacturers accounted for 11 of the 194 total clearances - 6% of all May activity.

About this data

This report covers FDA 510(k) submissions with a decision date in May 2021 and a valid days-to-decision value. Data is sourced from the FDA 510(k) public files, published on the 5th of each month and in the public domain (17 U.S.C. § 105). Only cleared decisions are counted (SESE, SESK, SESU, SEKD, SESP, SESD, ST, SN).

Maintained by Space Bits, S.L. Not affiliated with or endorsed by the FDA. Verify at accessdata.fda.gov.